Retrospective Study Highlights Evolving Community Use of BTK Inhibitors for CLL/SLL
A retrospective cohort study acalabrutinib and zanubrutinib are being increasingly adopted for the treatment of CLL/SLL in the community setting.
A retrospective cohort study acalabrutinib and zanubrutinib are being increasingly adopted for the treatment of CLL/SLL in the community setting.
A reduced dosing duration of venetoclax plus hypomethylating agents may be appropriate for elderly patients with acute myeloid leukemia.
Find information on cancer survivorship, coping with cancer, cancer recurrence, and tips on staying active and healthy as a cancer survivor, during and after cancer…
Clinical trials test the safety and effectiveness of new cancer drugs and treatments. Search for Huntsman Cancer Institute clinical trials by cancer type, drug, or…
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Over 200 health journals call on the United Nations, political leaders, and health professionals to recognise that climate change and biodiversity loss are
Unquestionably, a child’s cancer diagnosis weighs heavily on the parents’ minds. But now, an analysis of nearly 30,000 U.S. families has quantified how often parents…
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Samuel Cytryn, MD, discussed first-line use of claudin-18.2 inhibitors for patients with…
WU-CART-007 has received RMAT and PRIME designations in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
If you need an omentectomy as a part of your cancer treatment, you probably have a lot of questions. We checked in with gynecologic oncologist…